4 recruiting, 3 completed, 2 terminated, 1 active not recruiting. 3 Phase 2, 2 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Not yet recruiting 1, Terminated 1 |
| Not applicable | 2 | Recruiting 1, Terminated 1 |
| Phase 4 | 2 | Recruiting 1, Unknown 1 |
Follow Cardiac Dysfunction: new trials by email Literature Review of Cardiac Dysfunction trials Research Report on Cardiac Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PEDIatric Cardiac Dysfunction Treated With Injectable Nicotinamide Adenine Dinucleotide Placebo, Nicotinamide Adenine Dinucleotide - Cardiac Dysfunction | Phase 2 | Not yet recruiting | Beijing Children's Hospital | 180 | 2026-10-01 | 2026-09-24 |
| Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Cardiotoxicity, DPP3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 400 | 2025-12-25 | 2026-09-25 | |
| Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction Yangxinshi tablet, Blank control - Coronary Heart Disease, Cardiac Dysfunction | Phase 4 | Recruiting | SPH Qingdao Growful Pharmacetical Co.,Ltd | 2708 | 2025-11-06 | 2025-11-25 |
| A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction Vericiguat, Optimal medical therapy - Breast Cancer, Cardiac Dysfunction | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 21 | 2023-07-17 | 2026-08-03 |
| Prognostic Role of the Uremic Toxin Indoxyl Sulfate on Vascular and Cardiac Functions During Acute Kidney Injury blood sample - Acute Kidney Injury, Uremic; Toxemia | Not applicable | Recruiting | Centre Hospitalier Universitaire, Amiens | 105 | 2022-12-13 | 2025-05-28 |
| Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). Pemziviptadil (PB1046), Low Dose (10 mg) Control - Acute Respiratory Distress Syndrome, Coronavirus | Phase 2 | Terminated | PhaseBio Pharmaceuticals Inc. | 54 | 2020-07-15 | 2020-12-11 |
| Football Players Health Study In Person Assessments Study Echocardiography, Neuropsychological Testing, Quantitative Sensory Testing - Cardiac Dysfunction, Neurocognitive Disease | Completed | Massachusetts General Hospital | 111 | 2019-04-22 | 2024-05-08 | |
| Cardiac Dysfunction in Childhood Cancer Survivors cardiac assessment - Cardiac Dysfunction, Cardiovascular Diseases | Recruiting | University of Bern | 500 | 2018-02-13 | 2026-05-29 | |
| Cardiac Arrhythmias and Dysfunction in the Pediatric Burn Patient Echocardiogram - Cardiac Dysfunction | Not applicable | Terminated | Shriners Hospitals for Children | 10 | 2017-05-03 | 2018-11-07 |
| Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Meropenem, Vancomycin, Remifentanil, Cefepime, Cefpirome, Sufentanil, Midazolam, Clopidogrel, Ticagrelor, Prasugrel During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO) Residual blood - Cardiac Dysfunction | Completed | Yonsei University | 56 | 2014-12-01 | 2019-11-13 | |
| MicroRNA Diagnostics in Subarachnoid Hemorrhage 2 Subarachnoid Hemorrhage, Delayed Cerebral Ischemia | Completed | Copenhagen University Hospital, Rigshospitalet | 70 | 2014-11-01 | 2015-05-27 | |
| Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block ropivacaine, saline - Cardiac Dysfunction, Myocardial Injury | Phase 4 | Unknown | Si-Qin Chen | 40 | 2014-04-01 | 2014-08-26 |
Arrhythmias, Cardiac (2) · Cardiotoxicity (2) · Cardiovascular Diseases (2) · Acute Coronary Syndrome (1) · Acute Kidney Injury (1) · Acute Lung Injury (1) · Breast Neoplasms (1) · Burns (1) · COVID-19 (1) · Chronic Pain (1) · Coronary Disease (1) · Coronavirus Infections (1) · Cytokine Release Syndrome (1) · Dyspnea (1) · Heart Failure (1)
Pathological Conditions, Signs and Symptoms (6) · Heart Diseases (5) · Pathologic Processes (5) · Cardiovascular Diseases (4) · Respiratory Tract Diseases (4) · Vascular Diseases (4) · Lung Diseases (3) · Myocardial Ischemia (3) · Wounds and Injuries (3) · Chemically-Induced Disorders (2) · Drug-Related Side Effects and Adverse Reactions (2) · Infections (2) · Inflammation (2) · Nervous System Diseases (2) · Radiation Injuries (2)
Echocardiography (2) · Sodium Chloride (2) · Blood Specimen Collection (1) · NAD (1) · Ropivacaine (1) · Saline Solution (1) · VIP-ELP fusion molecule PB1046 (1) · Yangxinshi (1) · vericiguat (1)
Assistance Publique - Hôpitaux de Paris (1) · Beijing Children's Hospital (1) · Centre Hospitalier Universitaire, Amiens (1) · Copenhagen University Hospital, Rigshospitalet (1) · Massachusetts General Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · PhaseBio Pharmaceuticals Inc. (1) · SPH Qingdao Growful Pharmacetical Co.,Ltd (1) · Shriners Hospitals for Children (1) · Si-Qin Chen (1) · University of Bern (1) · Yonsei University (1)
United States (4) · China (3) · France (2) · Denmark (1) · South Korea (1) · Switzerland (1)
Anthony Yu, MD, MS (1) · Claudia E Kuehni, MD (1) · Ivan Wilmot, MD (1) · Jin Wi, MD (1) · Meagan M Wasfy, MD, MPH (1) · Petra M Warner, MD (1)
PMID 28674057, PMID 31288863, PMID 32122899, PMID 32269016, PMID 33183322, PMID 34937189, PMID 39076617, PMID 39210710, PMID 39566404, PMID 40013746, PMID 41325279